RxDoctor Payments Data

Henry Youga

Family Medicine · Dublin, OHNPI 1144286857

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,428 of the $4,388 with a category attached, or 78.1%. 4 manufacturers reported payments, led by Novartis at 32.9% of the total.

$4,388in general payments, 2019–2025

Across 19 payments — averaging $230.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Boehringer Ingelheim International GmbH$1K
  • Modernatx, Inc.$1K
  • Eli Lilly$561
$644,511in research payments, 2019–2025

Across 177 payments — averaging $3641.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$172K
  • AstraZeneca$168K
  • Eli Lilly$161K
  • Novartis$58K
  • GSK$50K
  • Alnylam Pharmaceuticals Inc.$20K
  • plus $16K from 3 others

What the payments were for

  • Travel & lodging$3,42878%
  • Food & beverage$96122%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,388 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Other family medicine in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →